Sign inJoin waitlistJoin the waitlist

Saumil Gandhi

Associate Professor, Thoracic Radiation Oncology · University of Texas M D Anderson Cancer Center

Credentials: · · · · ·

History

University of Texas M D Anderson Cancer Center
Present

Radiation Oncology
University of Pennsylvania Health System
2012–2016
University of Pennsylvania
2011–2016
Albert Einstein College of Medicine
2007–2011

Research

Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study
The Lancet Digital Health · 2023 · 94 citations
High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: Results of a phase II trial
Radiotherapy and Oncology · 2021 · 81 citations
Radiation Therapy Enhanced by NBTXR3 Nanoparticles Overcomes Anti-PD1 Resistance and Evokes Abscopal Effects
International journal of radiation oncology · 2021 · 53 citations

John Heymach
18 papers
Quynh-Nhu Nguyen
17 papers
Steven Lin
17 papers
James Welsh
15 papers
Joe Chang
15 papers
Zhongxing Liao
14 papers
Matthew Ning
11 papers · 4 as a resident
Mehmet Altan
11 papers
Aileen Chen
10 papers
Percy Lee
9 papers
Ajay Sheshadri
8 papers
Ara Vaporciyan
8 papers

Clinical trials

Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid Malignancies
Principal investigator · Recruiting · Phase 1, Phase 2
M.D. Anderson Cancer Center
2023–2028
Feasibility, Safety, and Efficacy of Stereotactic MRI-Guided Adaptive Radiation Therapy (SMART) for Central Lung Tumors
Principal investigator · Terminated
M.D. Anderson Cancer Center
2022–2025
NBTXR3 and Radiation Therapy for the Treatment of Inoperable Recurrent Non-small Cell Lung Cancer
Principal investigator · Active not recruiting · Phase 1
M.D. Anderson Cancer Center
2021–2028
Osimertinib, Surgery, and Radiation Therapy in Treating Patients With Stage IIIB or IV Non-small Cell Lung Cancer With EGFR Mutations, NORTHSTAR Study
Principal investigator · Active not recruiting · Phase 2
M.D. Anderson Cancer Center
2018–2027